Healthcare Business Review: Dendreon Shares COLLAPSE, Humana Shares Its MISS

Here are Tuesday’s top stories:

Dendreon Corporation (NASDAQ:DNDN) shares fall more than 20 percent on Tuesday, subsequent to its bleak second quarter earnings report and restructuring announcement late Monday. In reaction, Deutsche Bank, JPMorgan, and Lazard all downgraded the shares, while Jefferies and Baird both reduced their price targets.

Don’t Miss: Pfizer Earnings: Profit Jump BREAKS Streak of Falling Profits.

Humana Inc. (NYSE:HUM) sneezed, and shares of Aetna, Inc. (NYSE:AET), WellPoint, Inc. (NYSE:WLP), and UnitedHealth Group Inc. (NYSE:UNH) all caught cold, subsequent to the former missing its second quarter earnings and reducing its margins outlook on Monday.

Don’t Miss: Healthcare Realty Trust Earnings: Profits Rises as Revenue Ticks Up.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Premium Newsletters

Stock Investor Cheat Sheet

Stock Investor Cheat Sheet®

The ultimate Cheat Sheet for finding winning stock picks.
Learn More

Gold & Silver Newsletter

Gold & Silver

Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More

Commodities Premium Newsletter

Commodities Premium

There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more

ETF Investing

ETF Investing

At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business